3D Printing for Healthcare is the topic of our next event, AMA: Healthcare on June 4th.
Few technologies have moved as quietly, yet as persistently, into clinical spaces as 3D printing. What once belonged exclusively to engineering labs has gradually found its footing in operating rooms, medical schools, and patient consultations.
Rand Kittani, resident physician in general surgery at Stanford and founder of CIM3D, has been part of that transition, not as a passive observer, but as someone actively building the infrastructure that connects printing technology to patient outcomes.
Want to stay ahead in healthcare? Don’t miss our AMA: Healthcare 2026 online conference, sign up now!
Printing That Meets the Patient Where They Are
The appeal of 3D printing in medicine is not simply that it produces things faster. It is that it produces things differently, shaped around individual anatomy, specific conditions, and the particular circumstances of each patient. Surgical guides, spinal implants, dental devices, orthopedic casts, and breast prosthetics are among the applications already in use today, each representing a shift away from one-size-fits-all solutions toward something more responsive.
At Carle Illinois, Kittani launched CIM3D to give that work a home. The lab brought together printers, materials, and collaborative research projects, and it served as a testing ground for ideas that connected classroom learning to clinical reality.
One such project produced a 3D printed surgical guide for orbital floor fractures, a delicate procedure involving the thin bone beneath the eye socket. The guide was built to support surgeons in navigating anatomy that is difficult to visualize intraoperatively, particularly in settings where case volumes are low or access to specialized planning tools is limited. The intended beneficiary was not just the surgeon, but the patient in a rural clinic who might otherwise wait weeks for a customized solution to arrive from an outside vendor.
Closing the Gap Between Technology and Treatment
Two research efforts led by Kittani’s team illustrate a recurring challenge: the gap between what 3D printing can do and what patients are willing or able to accept.
The first involved custom breast prosthetics for mastectomy patients. Using a free smartphone scanning app, MRI images, and accessible design software, the team produced anatomically matched prosthetics at a fraction of the time and cost associated with conventional suppliers. The aim was not to compete with reconstructive surgery, but to offer something meaningful during the months-long window between mastectomy and reconstruction, a period when many patients have no affordable or accessible option.
Patient interviews exposed a sharp contrast in reception. Those who had not yet experienced surgery were unfamiliar with the technology and defaulted to skepticism. Those who had lived through the waiting period were far more receptive. As one patient shared, she wished during that bridging time there had been more options that were cost-friendly to help regain, momentarily, that sense of self after losing a part of her body.
The second project analyzed 3D printed orthopedic casts, comparing cost structures between established commercial providers and what a medical school lab could produce. Despite patient acknowledgment that printed casts offered better hygiene and a more precise fit, most respondents were only willing to pay between $100 and $150, well below what most commercial providers charge.
The data pointed to a structural tension that runs through most of 3D printing’s medical applications: the technology can outperform standard options, but affordability and insurance coverage remain decisive barriers.
The Cost Problem and What Manufacturers Could Do Differently
Kittani said that if awareness is the first barrier, affordability is the second, and it starts earlier than most assume. From Kittani’s perspective, the challenge is not just about what patients can pay at the point of care. It begins in medical school, where printing materials and equipment are maybe out of reach for student-run labs operating on limited budgets.
“If material is outside of our budget and printers are outside of our budget, it’s really hard to incorporate that into our education early on,” she noted. The downstream consequence is significant: clinicians who never encounter 3D printing during training are unlikely to seek it out once they enter practice.
The window for building that familiarity is narrow, and manufacturers who want broader clinical adoption have a direct role to play in making their tools accessible at the educational level, particularly for bioprinting, which Kittani identifies as among the most valuable and least affordable frontiers.
On the regulatory side, the picture is somewhat more encouraging. The growing availability of FDA-approved biocompatible materials has meaningfully reduced the compliance burden for healthcare professionals producing custom devices. Unless a team is developing entirely novel materials, much of the validation groundwork has already been completed, lowering a barrier that once felt insurmountable.
AI, Collaboration, and the Road Ahead
The integration of AI into 3D printing workflows is already underway, with early applications focused on automating design generation and customizing outputs to individual patient parameters. Kittani sees this as a natural extension of the personalization that printing already enables, moving from generic answers to condition-specific solutions in real time. Rather than a patient describing vague symptoms, AI-assisted tools can factor in age, diagnosis, and medical history to generate a tailored response or device recommendation.
But technology alone will not drive adoption. Kittani is clear that the mindset shift required among clinicians cannot happen in isolation. “The shift should be collaborative between industry partners, healthcare advocates, and how they connect with doctors,” she said, framing it as a shared responsibility rather than something physicians must arrive at on their own.
As for the long-term trajectory, her outlook is expansive. The surgical space, she believes, has the most immediate room to grow, in tools, equipment, prosthetics, and eventually bioprinted tissue.
The economics are moving in the right direction too. As printing becomes more cost-effective over time, the technology will reach clinical settings that previously could not justify the investment. The ceiling, as she puts it, is not yet visible.
What 3D Printing Unlocks for Patients and Clinics
The case for 3D printing in healthcare is no longer built on potential alone, it is increasingly backed by documented outcomes across institutions worldwide. What was once dismissed as a niche engineering curiosity has matured into a clinical tool reshaping how hospitals plan surgeries, produce devices, and serve patients who fall outside the reach of conventional care.
For instance, at Boston Children’s Hospital, the Cardiovascular 3D Modelling and Simulation Program has produced over 1,600 patient-specific models since 2018, covering roughly 50% of all operating room surgical cases last year alone, with lead surgeon Dr. David Hoganson crediting the technology with allowing teams to “do things right the first time,” directly reducing reinterventions and ICU recovery time.
At the operational level, Ricoh’s point-of-care studio at Atrium Health Wake Forest Baptist reports 62 minutes saved per surgery, $3,720 in cost reductions per case, and half of surgeons changing their surgical approach after using a printed model during planning.
The deeper shift is personalization. Cairn Surgical’s Breast Cancer Locator System uses a patient-specific 3D printed form derived directly from MRI scans to map tumor size and location during breast-conserving surgery, replacing generic reference points with that patient’s exact anatomy. At Salzburg University Hospital, clinicians designed and printed a personalized occipital prosthesis directly from a patient’s scans, in-house.
Across all these cases, the pattern is the same: the patient’s own anatomy becomes the blueprint, not an afterthought. As Kittani’s work at Carle Illinois demonstrates, closing that gap does not require a large institution or an outsized budget, just the will to act on what the technology already makes possible.
3D Printing Industry is inviting speakers for its 2026 Additive Manufacturing Applications (AMA) series, covering Energy, Healthcare, Automotive and Mobility, Aerospace, Space and Defense, and Software. Each online event focuses on real production deployments, qualification, and supply chain integration. Practitioners interested in contributing can complete the call for speakers form here.
To stay up to date with the latest 3D printing news, don’t forget to subscribe to the 3D Printing Industry newsletter or follow us on LinkedIn.
Explore the full Future of 3D Printing and Executive Survey series from 3D Printing Industry, featuring perspectives from CEOs, engineers, and industry leaders on the industrialization of additive manufacturing, 3D printing industry trends 2026, qualification, supply chains, and additive manufacturing industry analysis.
Register now to learn from healthcare AM leaders and expand your network across medical, dental, pharma, and regenerative manufacturing.
Featured image shows AMA: Healthcare 2026. Image via 3D Printing Industry.
